Current trends in molecular classification of adult renal tumors

Urology

Volumn 67, Issue 5, 2006, Pages 873-880

  Young, Andrew N ^a,b   Dale, Jennifer ^c   Yin Goen, Qiqin ^a,b   Harris, Wayne B ^a,b   Petros, John A ^a,b   Datta, Milton W ^a   Wang, May D ^c   Marshall, Fray F ^a   Amin, Mahul B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c Emory University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE IX ANTIBODY; IMATINIB; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE INHIBITOR; TEMSIROLIMUS; UNCLASSIFIED DRUG; TUMOR MARKER;

CANCER GENETICS; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CLINICAL PROTOCOL; CLINICAL TRIAL; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; METASTASIS; MICROARRAY ANALYSIS; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE; WORLD HEALTH ORGANIZATION; ADULT; CLASSIFICATION; DNA MICROARRAY; GENETIC MARKER; GENETICS;

ADULT; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; KIDNEY NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33646840078     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.11.042     Document Type: Review

References (60)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
2. Parkin D.M., Pisani P., Lopez A.D., et al. At least one in seven cases of cancer is caused by smoking. global estimates for 1985. Int J Cancer 59 (1994) 494-504
3. Chow W.-H., Gridley G., Fraumeni J.F., et al. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343 (2000) 1305-1311
4. Eble J.N., Sauter G., Epstein J.I., et al. Tumors of the kidney. In: Eble J.N., Sauter G., Epstein J.I., et al. (Eds). WHO Classification of Tumours. Tumours of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon, France
5. Amin M.B., Amin M.B., Tamboli P., et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms. an experience of 405 cases. Am J Surg Pathol 26 (2002) 281-291
6. Takahashi S., Shirai T., Ogawa K., et al. Renal cell adenomas and carcinomas in hemodialysis patients. relationship between hemodialysis period and development of lesions. Acta Pathol Jpn 43 (1993) 674-682
7. Tickoo S.K., Lee M.W., Eble J.N., et al. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol 24 (2000) 1247-1256
8. Renshaw A.A., and Richie J.P. Subtypes of renal cell carcinoma. different onset and sites of metastatic disease. Am J Clin Pathol 111 (1999) 539-543
9. Homma Y., Kawabe K., Kitamura T., et al. Increased incidental detection and reduced mortality in renal cancer-recent retrospective analysis at eight institutions. Int J Urol 2 (1995) 77-80
10. Novick A.C. Laparoscopic and partial nephrectomy. Clin Cancer Res 10 (2004) 6322S-6327S
11. Mabjeesh N.J., Avidor Y., and Matzkin H. Emerging nephron sparing treatments for kidney tumors. a continuum of modalities from energy ablation to laparoscopic partial nephrectomy. J Urol 171 (2004) 553-560
12. Chan D.Y., and Marshall F.F. Partial nephrectomy for centrally located tumors. Urology 54 (1999) 1088-1091
13. Zisman A., Pantuck A.J., Dorey F., et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19 (2001) 1649-1657
14. Motzer R.J., Bacik J., Mariani T., et al. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20 (2002) 2376-2381
15. Atkins M.B., Regan M., and McDermott D. Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma. Clin Cancer Res 10 (2004) 6342S-6346S
16. Gordon M.S. Novel antiangiogenic therapies for renal cell cancer. Clin Cancer Res 10 (2004) 6377S-6381S
17. Moch H., Presti Jr. J.C., Sauter G., et al. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56 (1996) 27-30
18. Takahashi M., Kahnoski R., Gross D., et al. Familial adult renal neoplasia. J Med Genet 39 (2002) 1-5
19. Na X., Wu G., Ryan C.K., et al. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. J Urol 170 (2003) 588-592
20. Van Erp F., Van Ravenswaaij C., Bodmer D., et al. Chromosome 3 translocations and the risk to develop renal cell cancer. a Dutch intergroup study. Genet Couns 14 (2003) 149-154
21. Glukhova L., Lavialle C., Fauvet D., et al. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas. increased copy number and overexpression of the MET proto-oncogene. Oncogene 19 (2000) 754-761
22. Toro J.R., Nickerson M.L., Wei M.H., et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73 (2003) 95-106
23. Nickerson M.L., Warren M.B., Toro J.R., et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2 (2002) 157-164
24. Hughes T.R., Mao M., Jones A.R., et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 19 (2001) 342-347
25. Schena M., Shalon D., Davis R.W., et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
26. Lockhart D.J., Dong H., Byrne M.C., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14 (1996) 1675-1680
27. Ma X.J., Wang Z., Ryan P.D., et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5 (2004) 607-616
28. Schuetz A.N., Yin-Goen Q., Amin M.B., et al. Molecular classification of renal tumors by gene expression profiling. J Mol Diagn 7 (2005) 206-218
29. Yao M., Tabuchi H., Nagashima Y., et al. Gene expression analysis of renal carcinoma. adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol 205 (2005) 377-387
30. Higgins J.P., Shinghal R., Gill H., et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 162 (2003) 925-932
31. Takahashi M., Yang X.J., Sugimura J., et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 22 (2003) 6810-6818
32. Young A.N., Amin M.B., Moreno C.S., et al. Expression profiling of renal epithelial neoplasms. a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol 158 (2001) 1639-1651
33. Quackenbush J. Computational analysis of microarray data. Nat Rev Genet 2 (2001) 418-427
34. Eisen M.B., Spellman P.T., Brown P.O., et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95 (1998) 14863-14868
35. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98 (2001) 5116-5121
36. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346 (2002) 1937-1947
37. Brown M.P., Grundy W.N., Lin D., et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA 97 (2000) 262-267
38. Ball C.A., Awad I.A., Demeter J., et al. The Stanford Microarray Database accommodates additional microarray platforms and data formats. Nucleic Acids Res 33 (2005) D580-D582
39. Brazma A., Hingamp P., Quackenbush J., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29 (2001) 365-371
40. Spellman P.T., Miller M., Stewart J., et al. Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol 3 (2002) RESEARCH0046
41. Ashburner M., Ball C.A., Blake J.A., et al., Gene Ontology Consortium. Gene ontology. tool for the unification of biology. Nat Genet 25 (2000) 25-29
42. Boer J.M., Huber W.K., Sultmann H., et al. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 11 (2001) 1861-1870
43. Gieseg M.A., Cody T., Man M.Z., et al. Expression profiling of human renal carcinomas with functional taxonomic analysis. BMC Bioinformatics 3 (2002) 26
44. Skubitz K.M., and Skubitz A.P. Differential gene expression in renal-cell cancer. J Lab Clin Med 140 (2002) 52-64
45. Yamazaki K., Sakamoto M., Ohta T., et al. Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 22 (2003) 847-852
46. Furge K.A., Lucas K.A., Takahashi M., et al. Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res 64 (2004) 4117-4121
47. Sultmann H., von Heydebreck A., Huber W., et al. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival. Clin Cancer Res 11 (2005) 646-655
48. Young A.N., de Oliveira Salles P.G., Lim S.D., et al. Beta defensin-1, parvalbumin, and vimentin. a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol 27 (2003) 199-205
49. Martignoni G., Pea M., Chilosi M., et al. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 14 (2001) 760-767
50. Tretiakova M.S., Sahoo S., Takahashi M., et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 28 (2004) 69-76
51. Zhou M., Roma A., and Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med 25 (2005) 247-257
52. Copland J.A., Luxon B.A., Ajani L., et al. Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression. Oncogene 22 (2003) 8053-8062
53. Takahashi M., Rhodes D.R., Furge K.A., et al. Gene expression profiling of clear cell renal cell carcinoma. gene identification and prognostic classification. Proc Natl Acad Sci USA 98 (2001) 9754-9759
54. Vasselli J.R., Shih J.H., Iyengar S.R., et al. Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci USA 100 (2003) 6958-6963
55. Burczynski M.E., Twine N.C., Dukart G., et al. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clin Cancer Res 11 (2005) 1181-1189
56. Twine N.C., Stover J.A., Marshall B., et al. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 63 (2003) 6069-6075
57. Motzer R.J., Mazumdar M., Bacik J., et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17 (1999) 2530-2540
58. Brouwers A.H., Frielink C., Oosterwijk E., et al. Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma. Cancer Biother Radiopharm 18 (2003) 539-547
59. Amatschek S., Koenig U., Auer H., et al. Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res 64 (2004) 844-856
60. Abrahams N.A., and Tamboli P. Oncocytic renal neoplasms. diagnostic considerations. Clin Lab Med 25 (2005) 317-339